Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and

Julie B Mortensen1, Ida Monrad1, Marie B Enemark1

  • 1Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.

Abstract

Insights

Soluble programmed cell death protein 1 (sPD-1) and soluble PD-L2 levels are elevated in lymphoma patients. Higher sPD-1 correlates with adverse prognostic factors, suggesting potential clinical utility in immunotherapy targeting the PD-1 pathway.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • The programmed cell death protein 1 (PD-1) pathway is crucial for immune regulation and is often exploited by cancers to evade immune responses.
  • Soluble forms of PD-1 (sPD-1) and its ligands (sPD-L1/sPD-L2) are present in blood, but their clinical significance in lymphoma remains largely unknown.

Purpose of the Study:

  • To investigate the biological and clinical significance of soluble PD-1, PD-L1, and PD-L2 (sPD-1, sPD-L1, sPD-L2) in various lymphoma subtypes.
  • To explore the association of these soluble immune checkpoint molecules with prognostic factors and lymphoma characteristics.

Main Methods:

  • Serum samples from 131 lymphoma patients and 22 healthy individuals were analyzed.
  • Time-resolved immunofluorometric assay (TRIFMA) and enzyme-linked immunosorbent assay (ELISA) were employed to quantify sPD-1, sPD-L1, and sPD-L2 levels.

Main Results:

  • Lymphoma patients exhibited significantly higher serum levels of sPD-1 and sPD-L2 compared to healthy controls.
  • Elevated sPD-1 levels were associated with higher International Prognostic Index scores in diffuse large B-cell lymphoma.
  • Follicular lymphoma showed distinct patterns of higher sPD-1 and lower sPD-L1 levels, along with reduced ligand/receptor ratios, compared to other lymphoma types.

Conclusions:

  • This study provides the first comprehensive characterization of pretherapeutic sPD-1, sPD-L1, and sPD-L2 across diverse lymphoma subtypes.
  • The correlation of higher sPD-1 with adverse prognostic factors suggests a potential role in disease progression and clinical utility for immunotherapy.
  • Differential expression patterns, particularly in follicular lymphoma, may offer valuable biological insights for PD-1 pathway-targeted immunotherapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.9K